2.7 Contingency Planning: Power, HVAC, Supply and Staffing Failures

Key Takeaways

  • Contingency planning means deciding in advance, in written SOPs, what happens when HVAC, power, PECs, supplies, information systems or staff fail. It is task 1C8 of the BCSCP outline.

  • USP <797> requires microbiological air and surface sampling after any servicing of facilities or equipment, recertification after changes that could affect airflow, and a documented corrective action plan for out-of-range results.

  • If a PEC supplies part of a room's required air changes, it must not be turned off except for maintenance. Under USP <800>, work in a C-PEC stops immediately when it loses power; afterward the unit is decontaminated, cleaned and disinfected, and its recovery time is allowed before work resumes.

  • A 503A pharmacy may compound a copy of a drug that is on FDA's drug shortage list, because FDA does not treat a listed shortage drug as commercially available. 503B outsourcing facilities may also use shortage-list drugs.

  • Backup plans include qualified 503B suppliers, ready-to-use commercial products, Category 1 or immediate-use workflows while classified space is down, paper downtime procedures, and emergency power for PECs and HVAC.

Last updated: September 2026

2.7 Contingency Planning: Power, HVAC, Supply and Staffing Failures

Sterile compounding depends on many systems working at once: HVAC, HEPA filters, pressure monitoring, electricity, water, sterile supplies, trained people and software. The BCSCP outline lists contingency planning (task 1C8) as its own task, because patients still need their preparations when one of those systems fails. A strong plan is written, trained, drilled and reviewed. It sets out who decides, what stops, what continues under reduced conditions, and how the facility proves it has recovered.

Failure modes and required responses

FailureImmediate actionUSP requirement that shapes the response
Loss of room pressure or HVACStop compounding; close critical sites; notify the designated personContinuous pressure monitoring with daily documented review; a documented corrective action plan for out-of-range results; microbiological sampling after servicing (USP <797> 4.2.5, 5, 6.1)
Power outageStop work in affected PECs; protect open CSPs; move to emergency power if designedUSP <800>: if a C-PEC loses power, activities stop immediately. Afterward it is decontaminated, cleaned and disinfected, and the manufacturer's recovery time passes before work resumes
PEC failure or relocationTake it out of serviceRecertify after replacement or relocation of any PEC, then sample air and surfaces (USP <797> 5, 6.1)
Water leak or ceiling damageStop work; assess contaminationInsanitary-conditions risk under FDA guidance; clean, disinfect and apply sporicidal; sample; repair surfaces
Failed certification or action-level excursionRestrict the affected areaCorrective action plan; review follow-up data to confirm it worked (USP <797> 5.1, 6)
Storage temperature excursionQuarantine the affected CSPsThe designated person decides from literature or testing whether each CSP keeps its integrity, or discards it (USP <797> 19.1)

Two USP rules often surprise candidates. First, if a PEC's HEPA-filtered air is counted toward the room's 30 air changes per hour, that PEC must not be turned off except for maintenance, because switching it off drops the room below its design. Second, servicing any facility or equipment, including a HEPA filter change, triggers microbiological air and surface sampling before normal operation resumes.

Designing a degraded-mode workflow

When the cleanroom suite is down, the question is what can still be made safely. Common, defensible options include:

  1. Category 1 work in a certified PEC located in a segregated compounding area, if one exists, with Category 1 BUDs (12 hours at room temperature, 24 hours refrigerated).
  2. Immediate-use preparation at the point of care for doses that truly meet all seven USP <797> 1.3 conditions (see 1.4).
  3. Ready-to-use commercial products, such as premixed bags and prefilled syringes, which remove the need to compound.
  4. Outsourcing to a 503B facility. The supplier should be qualified in advance: FDA registration, inspection history (Forms 483, Warning Letters), product-specific testing and dating, and a quality agreement.
  5. Deferring non-urgent CSPs until the room is restored and sampling confirms control.

An SOP should state which option applies to which product and who authorizes the switch. Returning to normal status should require documented evidence: pressure restored, cleaning completed, sampling results reviewed and, if needed, recertification.

Supply and drug shortages

Shortages affect drugs, sterile 70% IPA, gloves, gowns, filters, growth media and syringes.

  • Substitution control: Any substitute supply (a different glove, filter or syringe brand) is checked for compatibility and suitability, and SOPs, MFRs and training are updated before use.
  • Compounding during drug shortages: For Section 503A, FDA does not consider a drug on its drug shortage list to be "commercially available." A pharmacy may therefore compound a copy of it without violating the essentially-copy restriction. Outsourcing facilities under 503B may likewise compound drugs that appear on FDA's shortage list.
  • Allocation and communication: The pharmacy works with prescribers and committees on therapeutic alternatives, dose rounding and conservation, and documents those decisions.

Information system downtime

IV workflow systems, ACD software, EHR order interfaces and label printers all fail sometimes. Downtime procedures should include paper compounding records that still capture every USP <797> Box 10 element, manual independent checks in place of barcode or gravimetric verification, and printed ACD recipes and calibration logs. On recovery, paper records are reconciled into the electronic system.

Staffing and competency gaps

A contingency plan must not quietly suspend personnel requirements. Anyone who compounds during an emergency still needs current garbing and aseptic manipulation competency. Cross-training more staff than the minimum schedule requires, and keeping competency dates staggered, stops qualifications from all lapsing at once.

Hazardous drug specifics (USP <800>)

  • A C-PEC that provides some or all of the C-SEC's negative pressure, or is used for sterile compounding, must run continuously. USP <800> suggests considering uninterruptible power for the ventilation that maintains negative pressure.
  • Spill kits and trained responders must be available whenever HDs are handled, including during emergencies and in non-routine locations.

Emergency power and design

ASHRAE design guidance for compounding pharmacies recommends putting PECs, room HVAC and pressure monitors on essential (backup) power circuits. A pharmacist reviewing a renovation should confirm which loads are on generator power and how long the backup lasts.

USP also published Operational Considerations for Sterile Compounding During Public Health Emergencies in October 2024. Use it as a reference when writing pandemic and disaster procedures.

Test Your Knowledge

A power interruption shuts down an externally vented Class II BSC used for sterile hazardous drug compounding in the middle of a preparation. What does USP <800> require?

A

Finish the preparation quickly on battery-powered lights, because the cabinet will restart

B

Stop activities in the C-PEC immediately; once power returns, decontaminate, clean and disinfect the cabinet and wait the manufacturer's recovery time before resuming

C

Move the open vials to a laminar airflow workbench to finish

D

Restart the cabinet and resume at once, since no HEPA filter was changed

Test Your Knowledge

The HVAC serving an ISO Class 7 buffer room is repaired after a 3-hour failure, and differential pressure is back to +0.025 inch water column. Which USP <797> requirement applies before routine compounding resumes?

A

None, because pressure has returned to normal

B

Microbiological air and surface sampling after the servicing, alongside the documented corrective action; recertification if the change could affect airflow or air quality

C

A new media fill for every compounder, with no environmental sampling

D

Only replacing all ceiling HEPA filters

Test Your Knowledge

During a nationwide shortage, an injectable appears on FDA's drug shortage list as currently in shortage. How does this affect a 503A pharmacy that wants to compound it from bulk drug substance for patients?

A

The pharmacy may never compound a copy of an FDA-approved drug

B

FDA does not consider the listed shortage drug commercially available, so compounding it does not violate the essentially-copy restriction; the pharmacy must still meet the other 503A conditions and USP <797>

C

The pharmacy becomes exempt from USP <797> during the shortage

D

The pharmacy may distribute unlimited quantities without prescriptions

Sections you finish are checked off in the contents.